Hengrui has established multiple R&D centers and clinical centers in the United States, Japan, and China. These centers operate in a concert and together lay a solid foundation for innovative drug discovery and development.
U.S. R&D CenterClinical Research, Business Development,and Regulatory Affairs with FDA
Japan R&D CenterRegistration, Sales, and Distribution of Advanced Formulations
Shanghai R&D CenterDiscovery of Lead Compounds and other Upstream Activities
Shanghai Clinical CenterClinical Development and Registration
Lianyungang R&D CenterManufacturing Process Development for Innovative and Generic Drugs; International Registration Research
Chengdu R&D CenterR&D of High Activity Compound, Hormones, and Contrast Agents
Nanjing R&D CenterDownstream of Shanghai R&D Center, API & Formulation Development